医学博士 - Columbia Global Centers

download report

Transcript 医学博士 - Columbia Global Centers

David P. ROYE, Jr., MD

President and Chief Executive Officer, International Healthcare Leadership

Dr. Roye is one of the world’s leading pediatric orthopaedic surgeons, and has spent decades providing care to children around the world. He is Chief of Pediatric Orthopaedic Surgery at the New York-Presbyterian Morgan Stanley Children’s Hospital, and St. Giles Professor of Pediatric Orthopaedic Surgery at the Columbia University College of Physicians and Surgeons. Dr. Roye’s volunteer work has taken him to Africa, Eastern Europe and to China. For the past twelve years, Dr. Roye has served as Chief Medical Officer of the Children of China Pediatrics Foundation, a not-for-profit organization that sends pediatric medical teams from the United States to China to provide medical education and perform surgeries on orphans to correct disfiguring birth defects and disabilities. In 2009 the American Association of Orthopaedic Surgeons honored Dr. Roye with the Humanitarian of the Year Award. Dr. Roye has recently been awarded faculty privileges at the Beijing Children’s Hospital.

Aware of the challenges facing healthcare reform in China, Dr. Roye founded International Healthcare Leadership (IHL). A non-profit organization, IHL designs and implements educational programs in health care management and policy for government officials and health care executives in China. By offering the annual course on campuses in the United States, IHL works to strengthen relationships between American and international health care leaders.

骆德唯,医学博士 国际健康领导者协会(



骆德唯医生是世界顶尖的儿科骨科医生。几十年来,他为世界各地 的儿童提供医疗服务。他是纽约摩根士丹利儿童医院骨科主任,也 是哥伦比亚大学内科与外科学院儿科骨科学 St. Giles 教授。 骆德唯医生在非洲,东欧以及中国开展志愿者工作。在过去的十 多年里,他一直担任中国儿科医疗基金会( CCPF )的医疗总监。 中国儿科医疗基金会是是一个非营利性组织,它派遣美国的儿科医 疗队伍到中国,为中国的医生提供医学教育并为中国孤儿实施手术 以帮助矫正其先天性的缺陷与残疾。去年,美国骨科学会为骆德唯 医生颁发了“年度人道主义大奖”。骆德唯医生最近还获得了在北 京儿童医院的行医资格。 在意识到中国所面临的医疗改革的挑战之后,骆德唯医生创办了 国际医疗保健领导协会( IHL )。 IHL 是一个非营利组织,其目的 是针对新兴国家的政府官员以及医疗卫生管理者设计和讲授医疗卫 生管理课程。通过每年一次的在美国进行的课程教学, IHL 致力于 加强美国与国际医疗卫生领导者的联系。

Professor Geng XIAO, PhD

Director, Columbia Global Centers (East Asia


Professor Geng Xiao is Director of Columbia Global Centers (East Asia ﹒ Beijing), established by the Columbia University. He is also an Honorary Professor at the University of Hong Kong, an Independent Director of the HSBC Bank (China) and the Genesis Emerging Markets Fund. Previously Professor Xiao was the founding Director of the Brookings-Tsinghua Center for Public Policy in Beijing, a Senior Fellow at the Brookings Institution, a tenured professor of economics at the University of Hong Kong, Head of Research and Advisor to the Chairman at the Securities and Futures Commission of Hong Kong, Vice President of the Chinese Economists Society in the US, a member of the board of supervisors at the Shenzhen Development Bank, a Faculty Associate at Harvard University, and a Consultant at the World Bank. Geng obtained his BSc in Management Sciences from the University of Science and Technology of China and his MA & PhD in Economics from UCLA. Professor Xiao has done extensive empirical and policy research on the Chinese economy, especially in areas of enterprise, macroeconomics, exchange rate, finance, and institutional economics, providing provocative, timely and useful policy analysis and recommendations. He also contributes frequently to public policy debates through media presences and conference presentations.

肖耿 教授,博士 哥伦比亚大学全球中心(东亚


肖耿教授现任哥伦比亚大学全球中心(东亚 • 北京)主任、香港 大学荣誉教授、汇丰银行(中国)以及英国 Genesis 新兴市场基 金公司( GEMF )独立董事。曾任清华 布鲁金斯公共政策研究中 心首任主任、美国布鲁金斯学会资深研究员、香港大学经济学 终身教授、香港证监会研究部主管及主席顾问、中国留美经济 学会副会长、深圳发展银行监事会监事、哈佛大学兼职研究员、 及世界银行顾问。 肖耿拥有中国科技大学管理科学学士及加州大学洛杉矶分校经 济学硕士及博士。肖教授的研究涉及中国经济的实证研究与政 策分析,特别在企业、宏观经济、汇率、金融及制度经济学领 域,提出过很多富有创意、及时且有效的分析和建议。肖教授 也通过媒体及会议积极参与公共政策辩论。

Lan XUE, PhD

Professor and Dean, School of Public Policy and Management; Executive Vice President, Development Research Academy for the 21st Century; Director of China Institute for Science and Technology Policy, Tsinghua University

Dr. Lan Xue is professor and Dean of the School of Public Policy and Management, Executive Vice President of the Development Research Academy for the 21st Century, and Director of China Institute for Science and Technology Policy at Tsinghua University. He is also an adjunct professor at Carnegie Mellon University. His teaching and research interests include public policy analysis and management, science and technology policy, higher education policy, and crisis management.

Dr. Xue has consulted for the World Bank, IDRC , APEC and other international organizations. He was the Chair of the Task Force for APEC 1998 Economic Outlook Report from 1997 to 1998. He is on the advisory board of many government agencies in China. In April 2003, he was invited to give a lecture to the top Chinese leadership on the issue of S&T Policy. Dr. Xue currently serves as a Vice President of China Association of Public Administration, Vice President of Chinese Association of Science of Science and S&T Policy, Vice Chairman of the National Steering Committee for MPA Education. He is also a member of the Visiting Committee for Kennedy School of Government at Harvard University and on the Board of Trustees of SciDev.Net.

Trained as an engineer, Dr. Xue has a Ph.D. in Engineering and Public Policy from Carnegie Mellon University and taught at the George Washington University before returning back to China. He is a recipient of 2001 National Distinguished Young Scientist Award in China.

薛澜,博士 清华大学公共管理学院教授兼院长,清华大学 策研究中心主任



清华大学公共管理学院教授兼院长,清华大学 学学术委员会副主任。薛澜 1991 21 世纪发展研 究院常务副院长,清华大学中国科技政策研究中心主任,清华大 年获美国卡内基梅隆大学工程与 公共政策博士学位后受聘担任美国乔治华盛顿大学助理教授。 1996 年回国任教于清华大学。主要研究方向为公共政策与管理、 科技政策与创新管理、危机管理等。曾获清华大学学术新人奖, 良师益友奖,优秀教学成果一等奖,国家自然科学基金委员会杰 出青年基金奖,长江学者特聘教授等。他还兼任中国行政管理学 会副会长、科学学与科技政策研究会副理事长、中国管理科学学 会副会长,国务院应急管理专家组成员,全国 MPA 教育指导委员 会副主任委员、国际发展研究中心( IDRC )董事、哈佛大学肯尼 迪政府学院顾问委员会委员、世界经济论坛全球行动委员会巨灾 委员会副主席、国际风险治理学会学术委员会委员,卡内基梅隆 大学兼职教授等。

Professor Guoen LIU, PhD

Professor of Economics and Executive Director for The Health Economics and Management Institute (HEMI), Peking University Guanghua School of Management; and Director of the PKU Center for Health Economic Research

Prior to Peking University, Dr. Liu served as tenured associate professor at University of North Carolina at Chapel Hill (2000 – 2006); and assistant professor at the University of Southern California (1994 – 2000). He received his PhD in economics from the City University of New York Graduate Center in 1991, and post-doctoral training in health economics from Harvard University in 1994. Dr. Liu currently serves on the State Advisory Council for Health Reform, the State Ministry of Human Resources and Social Security, and the State Ministry of Health Commission for Emergent Public Health. He also chairs the Expert Panel for the Chengdu Municipal Government Health Reform Taskforce, the Chinese Society for Pharmacoeconomics and Outcomes Research. He was the 2005-2006 President of the Chinese Economists Society ( Outcomes Research ( www.China-CES.org



), and the founding chair of Asian Consortium for the International Society for Pharmacoeconomics and Dr. Liu serves as Co-Editor for the ISPOR official journal of Value in Health, Editor-in Chief for the China Journal of Pharmaceutical Economics; and on the editorial board for Global Handbook of Health Economics, Chinese Journal of Health Economics, and European Health Economic Review. His primary research interests include health and development economics, health policy reform, and pharmaceutical economics. Dr. Liu’s current research projects are funded by the National Science Foundation, NIH, UNICEF, World Bank, and the State Council Expert Panel on the Urban Resident BMI.

刘国恩 教授,博士 北京大学应用经济学教授;北京大学卫生经济研究所 执行主任;中国药物经济学与效用研究中心主任

刘国恩博士 – 北京大学光华管理学院经济学教授,北大光华卫生经 济与管理研究院执行院长,北京大学中国卫生经济研究中心主任, 博生导师。刘国恩教授曾执教美国南加利福尼亚大学( 1995-1999 );美国北卡大学( 2000 终身教职);中国留美经济学会 2004 2005 届主席;以及国际医药经济学会亚太联合会主席。 在国家政策咨询方面,刘国恩教授担任国务院国家医改专家咨询委 员会委员,国务院城镇居民医疗保险试点评估专家组成员,国家人 力资源与社会保障部专家委员会委员,国家卫生部突发公共卫生事 件专家委员会委员,成都市人民政府医改专家组组长等职。 在学术研究领域,刘国恩教授担任中国药物经济学专业委员会主任 委员,国际药物经济学会官方期刊《 Value in Health 》副主编,《 中国药物经济学》杂志主编,以及《 Global Handbook of Health Economics 经济学。 》,《 European Health Economic Review 》编委等。刘国 恩教授的研究方向为健康与发展经济学,医疗体制改革,以及医药


Professor of Clinical Pediatrics, Columbia University Medical Center; Hospital Epidemiologist, NewYork-Presbyterian Morgan Stanley Children's Hospital

Dr. Lisa Saiman received her medical degree from Albert Einstein College of Medicine in the Bronx, New York. She performed her pediatric residency and subspecialty training in pediatric infectious diseases at Columbia University. She joined the Department of Pediatrics at Columbia University in 1989 and received her Masters of Public Health in Epidemiology from Columbia University in 1999. Dr. Saiman is currently Professor of Clinical Pediatrics in the Department of Pediatrics at Columbia University and the Hospital Epidemiologist at NewYork-Presbyterian Morgan Stanley Children’s Hospital. Dr. Saiman’s primary research and clinical interests are in cystic fibrosis (CF), healthcare-acquired infections, multidrug-resistant pathogens, and antimicrobial stewardship. She is the principal investigator of her divisions T-32 fellowship training grant in pediatric infectious diseases. She has served as a division chair for the American Society of Microbiology and serves on the Editorial Board of the journals Infection Control and Hospital Epidemiology and the Archives of Pediatric & Adolescent Medicine.


,医学博士,公共卫生硕士 哥伦比亚大学医学中心临床儿科学教授,纽约长 老会摩根士丹利儿童医院流行病学家

Lisa Saiman 医生从纽约布朗克斯的爱因斯坦医学院获得医学 学位。她在哥伦比亚大学医学院完成了住院医师培训,并在 此进行儿科传染病专科培训。 她于 1989 年进入哥伦比亚大学 儿科系,并于 1999 年获得哥伦比亚大学流行病学公共卫生硕 士学位。 科教授,并且是纽约长老会摩根士丹利儿童医院的流行病学 家。 Saiman 博士目前在哥伦比亚大学儿科部担任临床儿 Saiman 博士的主要研究方向是囊性纤维化( CF )、医疗感染、 多药耐药病原体以及抗生素监管。她是儿科传染病方面的 T-32 研究培训基金的主要负责人。她曾担任美国微生物学会的分 部主席 ,并担任期刊《感染控制 和医院流行病学》和《儿科 和青少年医学档案》的编委会成员。

Katharina JANUS, PhD, MBA

Professor of Healthcare Management at Ulm University, Germany, and the Director of the Center for Healthcare

Management, a global research network

Professor Janus also holds appointments at Columbia University’s department of health policy and management and at the University of California, Berkeley.

Prof. Janus focuses her research on the design and implementation of monetary and non-monetary incentive systems in healthcare organizations in order to support decision-making of healthcare professionals in complex situations and to change their behavior. Based on theories of organizational psychology Prof. Janus implements postmodern leadership structures in order to create learning systems, thereby reducing medical errors. She has been the principal investigator of several international studies on physician motivation and professional culture in collaboration with the Hannover Medical School, the University of California at Berkeley and Stanford University, USA. Additionally, Prof. Janus has been involved in political advisory councils and managed care projects on a national and international level.

Born in Eutin (Northern Germany) in 1975, Dr. Janus earned her Master's Degree in Business Administration at the University of Hamburg and the Université Panthéon-Sorbonne Paris in 2000. She holds a PhD in Business and Social Sciences from Helmut-Schmidt University in Hamburg (2003). Dr. Janus was a 2006-07 Harkness Fellow in Health Care Policy at The Commonwealth Fund.

Katharina JANUS

,博士, 工商管理硕士 德国乌尔姆大学医疗管理教授,医疗管理中心(一个 全球研究网络)主任, 她也在哥伦比亚大学卫生政策 部门以及加州大学伯克利分校任职

Janus 教授的研究主要关注在医疗机构实施金钱和非金钱的激励 制度 ,其目的是为了支持医护专业人员在复杂情况下的决策制定 并且影响他们的行为。为了创建学习系统, Janus 教授根据组织 心理学理论,实施了后现代的权利和领导结构,从而减少了医疗 差错。她与美国的汉诺威医学院、加州大学伯克利分校以及斯坦 福大学合作进行研究,是几个关于医生积极性和专业文化的国际 研究项目的主要研究员。此外, Janus 教授曾在政治顾问委员会任 职,并参与了几个国家级和国际级的卫生项目。 Janus 博士于 1975 年在 Eutin (德国北部)出生,于 2000 年在汉堡 大学以及巴黎一大获得了工商管理硕士学位。 2003 年,她从德国 汉堡的赫尔姆特 • 施密特大学获得了商业和社会科学博士学位。 Janus 博士是 2006-07 年度联邦基金会医疗政策研究员。

Professor Xiaoqing ZHOU

Director of Pharmacy, Professor, Former Director of the PLA General Hospital, Director of Pharmacy Division

Professor Zhou is currently a member of the Chinese Pharmaceutical Association, deputy Secretary of Chinese Licensed Pharmacist Association, deputy editor of the “Chinese Licensed Pharmacist” Magazine, and a member of the editorial board of several professional journals.

Professor Zhou is the chief editor of 21 medical books, author of more than 100 articles, winner of nine Science and Technology Progress Awards for medical achievements in “Post-Antibiotic Effect Series of Excellent Research and Administration Program” and in the “Study of Drugs: Quality Control Methodology.”

周筱青 教授 主任药师、教授;原解放军总医院药材处处 长;主任药师

周筱青教授现任卫生部合理用药专家委员会委员、 中国药学会理事、中国执业药师协会副秘书长、 《中国执业药师》杂志副主编,并担任多种专业刊 物编委。 她曾主编、参编学术著作 21 部,发表学术论文 100 余篇,获军队科技进步奖、医疗成果奖 9 项。代表 性成果包括《抗生素后效应系列研究与给药方案优 化》,《药品、制剂质量控制方法学的研究》 等。


Ph.D., Associate Professor and Master Instructor of School of Public Health, Health Policy and Management at Peking University Health Science Center

Dr. Li Yang graduated in 1999 from Huaxi Medical University with a Master of Science. In 2004, Yang graduated from Fudan University with a Ph.D. in Management. Yang also received a postdoctoral degree in 2009 from University of Vienna, Austria and was a visiting scholar at Harvard Medical School in 2011. Dr. Yang is a member of the International Health Economics Association, and the International Society of Pharmacoeconomics and Outcome Research (ISPOR) of Asia Pacific area. She serves as the Editor for the China Journal of Pharmaceutical Economics and the Chinese Practice of Pharmacist and Drug Evaluation. Her primary research interests include pharmaceutical economics, drug policy, the economic impact of chronic diseases, intervention strategies, health economics and health policy reform.

Dr. Yang presided over the “Basic Policy Research related to Drug Production,” the “Pricing Mechanism for Essential drugs and impact,” and the "Evaluation of Policy on Essential Drugs Based on the New Rural Cooperative Medical System." These research projects were funded by the National Natural Science Foundation, China’s Ministry of Health and Ministry of Education.

杨莉,博士 博士,北京大学医学部公共卫生学院卫生政策与 管理系副教授、硕士生导师

杨莉博士于 1999 年毕业于华西医科大学(现四川大学华西医学 中心),获硕士学位; 2004 年毕业于复旦大学,获管理学博士 学位。 2009 年在奥地利维也纳大学进行博士后研究。 2011 年在 哈佛大学医学院担任访问学者。 杨莉博士是国际卫生经济学会会员,国际药物经济学与结果研 究学会 (ISPOR) 亚太组委会成员,并且担任中国药物经济学、中 国执业药师、药品评价等杂志的编委。她的主要研究方向为: 药物经济学和药品政策、慢性病经济影响及干预策略、卫生经 济与卫生改革研究。 她曾主持了 “基本药物生产相关政策研究”、“定价机制对基 本药物提供和使用的影响”、“基于新农合的基本药物制度实 施效果评价研究”等由国家自然科学基金、卫生部、教育部资 助的十多项科研课题。她还参与了北京大学“国家医改建议方 案研究”、“中国中老年人健康和养老调查”、“健康中国 2020” 、“抗生素滥用的公共安全研究”、“基本药物制度监测 与评价可持续研究”等由国际组织、科协、各部委委托的重大 项目研究。

Professor Didier PITTET, MD, MS, CBE

Hospital Epidemiologist and Director of the Infection Control Programme and WHO Collaborating Centre on Patient Safety at the University of Geneva Hospitals; Faculty of Medicine, Geneva, Switzerland; Professor of Medicine and Hospital Epidemiology, University of Geneva

He holds Honorary Professorships at Imperial College London, UK, the Faculty of Health and Social Sciences, Hong Kong Polytechnic University School of Health Science, and the First Medical School of the Fu, Shanghai, China. Professor Pittet is Lead of the World Health Organization First Global Patient Safety Challenge “Clean Care is Safe Care”. He is the recipient of several national and international honours including a CBE (Commander of the British Empire) awarded by Her Majesty Queen Elisabeth II for services to the prevention of healthcare associated infection in the UK (2007), the Society for Healthcare Epidemiology of America Lectureship for his contribution to infection control and healthcare epidemiology (2008), and the European Society of Clinical Microbiology and Infectious Diseases’ Award for Excellence (2009). Professor Pittet is co-author of more than 400 publications in peer-reviewed journals and 50 chapters in textbooks; his current research interests include the epidemiology and prevention of healthcare-associated infections, methods for improving compliance with barrier precautions and hand hygiene practices, as well as innovative methods for improving the quality of patient care and patient safety. He is also involved in research on the epidemiology of infectious diseases. The experience of his team in engaging nations and healthcare settings worldwide in a universal commitment to patient safety is unique.

Professor Didier PITTET

,医学博士, 理学硕士,大英帝国勋章获得者 日内瓦大学流行病学家、控制感染项目主任、世界卫 生组织患者安全合作中心主任;瑞士日内瓦大学医学 院医学教授

Pittet 是英国伦敦帝国学院医疗及社会科学院、香港理工大学健 康科学学院、复旦大学医学院名誉教授。 Pittet 教授是世界卫 生组织第一全球患者安全项目“清洁的护理是安全的护理”的 领导者。 他多次获得国家级和国际级荣誉,包括英女皇伊丽莎 白二世颁发的大英帝国勋章,以表彰其在防止医疗感染上作出 的贡献( 2007 );美国流行病学讲师医疗协会的奖章,表彰其 在感染控制和医疗保健流行病学方面的贡献( 2008 );以及欧 洲协会临床微生物学和传染病优秀奖( 2009 )。 Pittet 教授是 在评审期刊发表的 安全。 400 余篇论文的合著者,也合作编写过 50 余 章教科书。他目前的研究方向包括:流行病和医疗感染的预防 ,改善隔离预防和手部消毒的方法,提高病人护理质量和病人



Managing Director, Joint Commission International, Asia Pacific Office

In this capacity, Dr. Paul Chang is responsible for furthering the development of relationships between JCI and Asia-Pacific health care organizations and works with regional Ministries of Health, other governmental agencies, NGOs, hospitals, laboratories and other health care organizations in their efforts to reduce risk and improve health outcomes. Prior to this, Dr. Chang was overseeing clinical quality, risk management, quality improvement and JCI accreditation in Changi General Hospital, an 800 bed Singaporean public hospital, and was part of the management team that led the hospital to achieve JCI accreditation in June 2005 as well as JCI Disease specific certification in 2 Cardiology programs – Acute Myocardial Infarct management and Heart Failure Management - in January 2007. Dr. Chang also has working experience in both the Singapore Ministry of Health and in various Singapore hospitals. Dr. Chang earned his medical degree and his Masters in Public Health from the National University of Singapore. He is a Certified Professional in Healthcare Quality and is also a trained JCI accreditation surveyor.


, 内外全科医学士,公共 卫生硕士,




国际联合委员会亚太地区办事处 董事总经理

Paul CHANG 医生目前的职责包括促进国际医院管理标准 (JCI) 和亚太地区医疗保健机构间的关系发展;并与区域卫 生部、其他政府机构、非政府组织、医院、实验室和其 他医疗保健机构合作,降低医疗风险并改善医疗状况。 在此之前, Paul CHANG 医生在新加坡樟宜综合医院(一 间拥有 800 个床位的公立医院)工作,负责监督临床质量, 风险管理,质量改进和 JCI 评审。在他所在的管理团队的 领导下,医院在 2005 年 6 月通过了国际医院管理标准评审。 2007 年 1 月,医院的两个跟心脏有关的研究项目 —— 急性 心肌梗死治疗和心力衰竭治疗 —— 获得了 JCI 的疾病特殊 认证。 Chang 医生还拥有在新加坡卫生部和新加坡多家医 院工作的经验。 Chang 医生在新加坡国立大学获得公共卫生硕士学位,获 得过专业医疗质量认证,并且是受过专业培训的 JCI 评审 员 。


Associate Professor, Mailman School of Public Health, Columbia University

Peter Muennig has also worked as a consultant for the Centers for Disease Control and Prevention and the Canadian government, on multiple international projects, and he founded the Burmese Refugee Project, an NGO in Northern Thailand. His primary area of research interest is in the evaluation of the health effects of major social policies, such as early childhood interventions, lead control, housing, and community enhancements. He has been published over 50 research papers and has authored two textbooks. His work has appeared on NPR, CNN, MSNBC and multiple times in major print media sources, such as the New York Times and Slate.


,医学博士, 共卫生硕士 哥伦比亚大学公共卫生学院副教授

Peter Muennig 是哥伦比亚大学的副教授。他曾任 疾病控制和预防中心和加拿大政府的顾问,负责多 个国际项目。他还在泰国北部创立了一个非政府组 织 —— 缅甸难民营。他的主要研究方向是评估重大 的社会政策对公众健康的影响,如儿童早期干预、 导向控制、住房和社会改革。他已发表了超过 50 篇 研究论文,并撰写了两本教科书。他的作品曾被 NPR, CNN, MSNBC 引用并多次出现在各大平面媒体 ,例如《纽约时报》和《 Slate 杂志》。

Professor Bijie HU, MD

Chief Physician, Zhongshan Hospital of Fudan University

Dr. Chang earned his medical doctor degree from Shanghai Medical University in 1984. He has worked in clinical microbiology, lung infections, and hospital infection control for over 20 years and published more than 150 research papers. He has been the editor-in chief or vice editor-in-chief of 8 books, and co-editor of 28 books. He is currently the Vice Director of Fudan University Respiratory Diseases Research Center, and the Director of the Infectious Diseases Department, Clinical Microbiology Laboratory and Pneumology Department of Zhongshan Hospital of Fudan University.

胡必杰 教授,医学博士 复旦大学附属中山医院主任医师

胡必杰教授 1984 年毕业于上海医科大学医学系,从 事临床微生物、肺部感染以及医院感染管理工作二 十余年。已发表学术论文 专著 8 部,参编 28 150 余篇。主编或合作主 编《医院感染学》、《下呼吸道感染实验室诊断规 范》、《医院感染预防与控制的标准操作规程》等 部。现任复旦大学呼吸病研究所 副所长、肺部感染研究室主任,复旦大学附属中山 医院感染性疾病科主任、医院感染管理科主任、临 床微生物实验室主任、呼吸科主任医师。

Professor Yuanzhi GUAN

Professor in Microbiology, Dean of Department of Education Administration, PUMC

Professor Guan earned his Master's Degree in Medical Science at Chinese Academy of Medical Sciences in 1981. He was a 1984-85 WHO fellow in immunology and pathology at Geneva University and 1986-88 DANIDA fellow in Microbiology at Copenhagen University Hospital.

Professor Guan is editor of several medical journals and co-author of 9 textbooks; his current research interests include control of nosocomial infection and bio-safety.

管远志 教授 协和医科大学教务处处长、医学微生物学教授

管远志于 1981 年从中国医学科学院基础医学研究所毕 业,获微生物及免疫学专业硕士学位。 1984 至 1985 年赴瑞士日内瓦大学医学院进修免疫; 年在丹麦哥本哈根大学医学院进修临床微生物学;并 曾在 1996 1986 - 年在美国加州大学洛杉矶分校进修。 1988 管远志教授现任协和医科大学教务处处长。他还是高 等医学教育学会理事,《中华儿科》杂志、《中华临 床免疫及变态反应》杂志以及《基础医学与临床》杂 志的编委会成员,曾参与编写多部教科书。管远志教 授的主要研究领域为:从靶细胞的跨膜信号传导途径 探讨致病性大肠杆菌感染的非抗生素治疗 ( non antibiotic therapy ) 。

Michael GUSMANO, PhD

Associate Professor of Health Policy and Management, New York Medical College ; Research Scholar, The Hastings Center

Dr. Gusmano’s research interests include politics of health care reform, comparative health systems, health and health care inequalities, and normative theories of policy analysis. His most recent book, Health Care in World Cities (Johns Hopkins University Press, 2010), documents the implications of national and local health care policies for access to care in New York, London and Paris. He holds a Ph.D. in political science from the University of Maryland at College Park and a Masters in public policy from the State University of New York at Albany. He was also post-doctoral fellow in the Robert Wood Johnson Foundation Scholars in Health Policy program at Yale University (1995-1997). Dr. Gusmano is member of the Academy of Management, the American Political Science Association (APSA), the American Public Health Association, the Gerontological Society of America, and the serves as the secretary of APSA’s Organized Section on Health Politics and Policy. He is also on the editorial boards for the Journal of Health Politics, Policy and Law and Health Economics Policy and Law.


,博士 纽约医学院卫生政策与管理副教授,美国黑斯 廷斯生物伦理学研究中心研究学者

Gusmano 博士的研究兴趣包括医疗改革政策、比较卫生 系统、医疗和医保不平等以及政策分析的规范性理论。 他的最新著作《世界城市的卫生保健》(约翰霍普金斯 大学出版社, 2010 ),记录了国家和地方性的医疗政策 在纽约、伦敦和巴黎的的影响。 他拥有美国马里兰大 学帕克分校的政治学博士学位,以及美国纽约州立大学 奥尔巴尼分校的公共政策硕士学位。 他还是耶鲁大学 罗伯特伍德约翰逊基金会学者卫生政策计划方向的博士 后 (1995-1997) 。 Gusmano 博士是 美国政治科学协会( APSA )管理学院 的成员,美国公共卫生协会成员, 美国老年学学会成 员,并且担任 APSA 卫生行政与政策小组的秘书官。 他 还是《卫生行政、政策和法律》杂志以及《卫生经济政 策和法律》杂志的编委会成员。


Director of Hemodialysis, New York Veterans Affairs Medical Center; Chief of Clinical Nephrology, NYU Langone Medical Center; Professor of Medicine & Physiology, NYU School of Medicine

Dr. Goldfarb’s research has involved all aspects of chronic kidney disease and end stage kidney disease, including anemia, hyperparathyroidism and cardiovascular risk factors. He is also internationally recognized for his research in kidney stone pathophysiology and prevention.


,医学博士 纽约退休士兵医疗中心血液透析主任,纽 约大学


医疗中心临床肾脏病主任 ,纽约大学医学院医学和生理学教授

Goldfarb 教授的研究领域涉及慢性肾脏病和中 晚期肾脏病的各个领域,包括贫血症、甲状旁 腺功能亢进症和心血管疾病。他以在肾结石病 理生理学和预防方面的研究闻名国际。

Professor Yun-song YU, PhD

Assistant Dean and Director of Infectious Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

Prof. Yu is mainly engaged in research on the surveillance of bacterial resistance, the mechanism of bacterial resistance and the treatment of infections caused by multi-resistant bacteria. His work is supported by grants from the 973 Project, the 863 Project, and the National Nature Science Foundations of China (NNSF). He won the second national prize for progress in science and technology in 2007 and got the first and second prize for progress in science and technology of Zhejiang province in 2003 and 2000. Prof. Yu is Director of the Department of Infectious Diseases of Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University. He is also Vice Director of the Clinical Microbial Group of Chinese Microbial and Immune Association, Vice Director of Zhejiang Microbial and Immune Association, and editor of four medical journals.

俞云松 教授,博士 浙江大学医学院附属邵逸夫医院副院长、感染科主 任

俞云松教授现任浙江大学医学院附属邵逸夫医院副院长, 感染科主任, 2005 年获教育部新世纪优秀青年人才支持计 划基金( NCET-04-0552 )资助, 2007 年获浙江省首届卫生 高层次创新人才计划资助, 2008 年入选浙江省新世纪 151 人才工程第一层次 。俞教授长期从事传染科临床工作, 对感染性疾病,尤其是细菌感染性疾病的诊断和治疗有着 丰富的临床经验。 1990 年以来,一直从事细菌耐药机理、 耐药细菌感染及治疗的研究,以第一作者和通讯作者发表 SCI 收录论文 35 篇。先后主持国家自然科学基金 4 项,主持 973 子课题、 863 项目、卫生部行业基金各一项。 《 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 》、 《 JOURNAL OF MEDICAL MICROBIOLOGY 》等多家 SCI 论文审 稿人。

Professor Shan WANG, MD

President of Peking University People’s Hospital, Professor of Surgery

Prof. WANG has devoted himself to clinical medicine and hospital management. He has made significant achievements in medical education, clinical and basic medical research, modern hospital building and management, health management and public health promotion. He is a renowned surgeon as well as a healthcare leader both in China and internationally.

Prof. WANG graduated from Peking University in 1983 and did his research in tumor and trauma at the University of Texas Medical Branch 1995-1998.

王衫 教授,医学博士 北京大学人民医院院长、北京大学外科学教授

王杉教授长期从事外科临床医疗实践与行业管理工 作,在临床医学教育、医学临床科研与基础研究、 现代医院建设与管理、健康管理以及公共医疗卫生 事业的促进与发展等多个专业领域,做出了突出的 成绩,在国内外享有较高的声誉。 王杉教授 1983 年毕业于北京医学院(现北京大学医 学部)医学系, 1992 年获医学博士学位。 1995 年 — 1998 年在美国德克萨斯大学医学院外科从事外科肿 瘤及创伤相关研究 。


Senior Vice President, Chief Medical Officer, Chief Operating Officer, New York Presbyterian Hospital/Weill Cornell Medical Center

At New York Presbyterian, currently ranked #6 in US News among Best Hospitals, Dr. Forese has responsibility for programs, operations and strategic direction for 1100 medical, surgical and psychiatric beds on two campuses. Dr. Forese graduated summa cum laude, Phi Beta Kappa from Princeton University and Alpha Omega Alpha from Columbia University College of Physicians & Surgeons. A board-certified orthopaedic surgeon, she also holds a degree in health services management from Columbia University School of Public Health. After residency training at the Presbyterian Hospital in New York City, she assumed a faculty position in the Department of Orthopaedic Surgery at Columbia University. There she practiced pediatric orthopaedic surgery and held a series of management roles; she was Vice Chair until she left to become a full time hospital executive in 2003. Today, Dr. Forese has broad responsibility for the activities at NYP/WC that include day to day operations as well as long range planning. Under her leadership, NYP/WC has achieved significant improvements in efficiency, throughput, safety and patient and employee satisfaction.

Through her membership in multiple professional organizations and societies, she is a frequent speaker on management topics in medicine including communication skills, risk management, quality, compliance and business integrity. She is currently President Elect of the Chief Medical Officer Group at AAMC and is a member of the NIH Taskforce on the Future of the Biomedical Workforce. Dr. Forese is a Trustee of Princeton University and is active in community and charitable organizations. She is married to Robert J. Downey, a thoracic surgeon; they have twin daughters and a son.


,医学博士 纽约长老会医院




)高 级副总裁、首席医疗官、首席运营官

Laura L. Forese 这里, Forese 是纽约长老会医院 Weill 康奈尔医学中心( 医生负责两个校区的大约 1100 NYP/ WC )高级副总裁 、首席医疗官、首席运营官。纽约长老会医院是目前美国排名第六的医院,在 个病床的运营管理工作。 Forese 以优异成绩毕业于普林斯顿大学,并于哥伦比亚大学内科和外科学院获 得了医学博士学位。她是经过认证的骨科医生,并且拥有哥伦比亚大学公共卫 生学院的卫生服务管理学位。 经纽约长老会医院培训后,她承担起哥伦比亚大学骨科的教职。在那里,她从 事小儿骨科手术。与此同时,她还担任了一些管理职务,直到 2003 年离开哥伦 比亚大学成为全职的医院管理者。 Forese 医生在 NYP/ WC 主要负责中心日常运营以及长远规划。在她的领导下, NYP/ WC 在提高医院效率、接待能力、安全性、病人和员工满意度方面均取得 了显著成效。 Forese 医生是多个专业团体和协会的成员。她经常发表医学管理主题方面的演 讲,包括沟通技巧、风险管理、质量、合规性和业务完整性。她目前是美国医 学院协会( AAMC )首席医疗官小组的会长,并且是美国国立卫生研究院( NIH )特别工作组成员。 Forese 医生是普林斯顿大学的校董,活跃在各个社团和慈善机构。 她的丈夫是 胸外科医生 Robert j. Downey 。他们育有一对双胞胎女儿和一个儿子。

Hufeng WANG, PhD

Director of Healthcare Reform and Development Center, Deputy Director of Social Security Research Institute

WANG Hufeng, PhD Associate Professor, Deputy Director of Social Security Research Institute, Director of Healthcare Reform and Development Center. Professor Wang is responsible for the Masters in Public Administration program on Health Policy and Management at Renmin University. He has been instrumental in the development of the case studies that will be used as the foundation of the International Healthcare Leadership certificate course to be offered at Columbia University. Professor Wang’s research focuses on Public Health and Health Promotional Policy; Pharmaceutical Industrial Policy; Medical Security Policy; Public Hospital Reform; Social Security Fund Investment and Regulation; Employee Welfare Plan. Last year he traveled to three countries providing lectures on “Reform of China 's Health Care System: Issues, Challenges, and the Future.” Prior to his position at Renmin University, Professor worked for ten years in the Hospital of Heibei Province as an administrator, held the position of Deputy Director General, Deputy Director of Social Security Reform Working Commission, responsible for “National Social Security System Pilot Testing at the Social Security Bureau of Beihai, and served in the Ministry of Labour and Social Security, Department of Medical Security involved in a series of legislation drafting.

王虎峰,博士 医疗改革与发展研究中心主任、社会保障研究所副 所长

王虎峰, 博士,副教授,社会保障研究所副所长,中国人民大 学医改研究中心主任, MPA 公共卫生与医疗政策研究方向责任教 授。王虎峰教授参与研究的案例,已被选入哥伦比亚大学的国 际医疗领袖证书课程。王教授的研究重点有:公共卫生与健康 促进政策,药品产业政策,医疗保障制度政策,公立医院改革 ,社保基金投资和监管,员工福利计划等。他于去年在三个国 家举行演讲,演讲内容为《中国的医疗体制改革:问题,挑战 和前景》。 在调往人民大学工作前,王虎峰教授曾在河北省医院内从事了 十年管理工作;曾任广西北海市社保改革领导小组办公室副主 任、社会保险局副局长,负责“全国社会保障制度综合配套试 点”工作;曾在国家劳动和社会保障部医疗保险司工作,期间 参加了系列重要的法规文件起草工作。

David E. Wood

Managing Director, Healthcare and China & Hong Kong Healthcare Leader, PricewaterhouseCoopers

David Wood has over 30-years of hospital administration and healthcare consulting experience, both domestically in the United States, and internationally. He has served in senior management positions with the University of California hospital system as assistant director, the University of Colorado Hospitals as chief financial officer and director of hospital operations and the Sydney Kimmel Cancer Research Center as senior vice president. Internationally, he has served the Shakut Khanum Cancer Hospital and Research Center in Pakistan as president, the United Family Hospitals in China as president and chief executive officer and the New Century International Children’s Hospital in Beijing as president and chief executive officer. In his role with the New Century International Children’s Hospital, he was the only foreigner serving as president of a Chinese hospital. His consulting work has included assisting clients in a variety of engagements internationally including the United States, China, Germany, Vietnam, Greece, Austria, England, Canada and Gambia. In China, Pakistan, Gambia and Vietnam, he undertook hospital development activities and completed responsibility for oversight of the planning, design, construction and opening of hospitals to include all space planning, operational planning, strategic planning, financial forecasting, equipment and facility planning, work flow development, IT master plan and implementation, strategic and operational budgeting, development of staffing plan including all job descriptions and hiring of initial staff, governance issues and initial strategic marketing activities. In his consulting activity in China, Mr. Wood has assisted clients in engagements involving China market entry and strategic development, market research and feasibility studies, operational efficiencies including staffing, work flow analyses and medical staff development and due diligence reviews for financing and acquisition purposes as well as market entry activity for numerous start-ups and early-stage projects.

伍德威 普华永道医疗保健执行总监、中国和香港地区医疗行业 主管

伍德威先生拥有超过 30 年以上的医疗行业从业经验,先后在美国和世 界其它地区的众多医疗健康服务机构工作,如在美国加州大学医学部 担任助理主任、在科罗拉多大学附属医院担任财务总监及医院运营总 监、在悉尼金梅尔癌症研究中心任高级副总裁。在亚太地区,他历任 巴基斯坦 Shakut Khanum 癌症治疗和研究中心总裁,以及和睦家国际 医院的总裁和首席执行官。在他为北京新世纪国际儿童医院工作时, 伍德威先生是唯一一位在华担任中国医院院长的外国人。 伍德威先生的咨询客户遍布全球,业务范围多样,涉足的地区包括 中国、美国、英国、奥地利、德国、希腊、越南、冈比亚等地。他曾 在在中国 , 巴基斯坦 , 赞比亚和越南建立医院发展战略 ,其中包括对于 医院建立的整体规划,设计包括医院的空间规划,业务规划,战略规 划,财务预算,设备和设施规划, 工作流程发展, IT 总体规划和实施 ,战略和业务预算,人员编制发展规划其中包括职位描述,第一批员 工的聘用,管理问题和最初的战略营销策划。 在其中国的咨询业务 中,他帮助客户签订进入中国市场的协议并制定战略发展计划,进行 市场调查,可行性研究,并进行运营效率管理,包括人员配置,工作 流程分析和医务人员发展管理。对财务和收购计划以及许多项目初期 阶段进行审慎调查与评估 .